#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia alpha Bronchopulmonary aspergillosis Amyotrophic lateral sclerosis gene carrier Chronic myelomonocytic leukaemia Lymphoma Kearns-Sayre syndrome Glycogen storage disease type II Adenovirus infection Adrenocortical carcinoma Angiosarcoma metastatic Cold type haemolytic anaemia Aicardi-Goutieres syndrome B-cell lymphoma refractory Skin angiosarcoma Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Treatment Behcet’s syndrome – Diagnostics Glycogen storage disease type I – Trials in Disease Haemophilia A without inhibitors – Basic Information Methylmalonic acidaemia – Treatment Leiomyosarcoma recurrent – Life with Disease Chondrosarcoma metastatic – Diagnostics Hyperoxaluria – Treatment Ewing’s sarcoma – Basic Information Progressive supranuclear palsy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Hydroxide Capivasertib L-Lysine Hydrochloride Clonazepam Bt8009 Xtmab-16 Paliperidone Estriol Atogepant Itraconazole RNMB2 LVT-001 Ammonium Chloride Bp TRONTINEMAB CHOLINE ALFOSCERATE POTASSIUM HYDROXIDE Bortezomib Cinchocaine Hydrochloride Heterodimeric Interleukin-15 Cldn6 Car-T More therapies…

    Learn about Your Condition

    Crohn's disease Arteriospasm coronary Neonatal hyperglycaemia Neurofibrosarcoma Primary hyperthyroidism Noninfective chorioretinitis Gastrointestinal melanoma Familial mediterranean fever Extraskeletal ossification Myocarditis post infection Magnetic resonance imaging Immunosuppression Dupuytren's contracture H1N1 influenza Rosai-Dorfman syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Oxytocin
    Spain

  • Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Amoxicillin
    • Clindamycin
    • Clavulanic Acid
    Denmark

  • Study of Repotrectinib for Frail or Elderly Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Rearrangement

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Repotrectinib
    France

  • Study on the Effectiveness of the Nonavalent HPV Vaccine in Treating Hard-to-Treat Palmar or Plantar Warts in Patients Who Have Not Responded to Two Previous Treatments

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    France

  • Study on the Safety and Effectiveness of Terbinafine Solution for Treating Mild to Moderate Nail Fungus in Children Aged 6-17 Years

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Terbinafine
    • Terbinafine Hydrochloride
    Denmark Iceland Italy Poland

  • Study on Shortened Antibiotic Treatment for Gram-negative Bacteremia in Hospitalized Adults Using Pivmecillinam Hydrochloride and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacteraemia
    Investigated Drugs:
    • Ampicillin
    • Gentamicin
    • Mecillinam
    Denmark
Previous Page
1 … 321 322 323 324 325 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!